Multimedia

Saad Usmani, MD, discusses the recent approval of daratumumab subcutaneous formulation for patients with multiple myeloma, and explains the major benefits of this treatment for this patient population.

Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.

Chris Caulfield, RN, NP-C, co-founder and chief nursing officer of IntelyCare, discusses misconceptions as well as advantages and disadvantages for facilities in relation to the gig economy, and provides future predictions for this market.

Benyam Muluneh, PharmD, assistant professor, UNC Eshelman School of Pharmacy, and Katie Buhlinger, PharmD, CPP, clinical pharmacist practitioner, UNC Medical Center, explain how pharmacists are correctly aligned to help manage the...

In this podcast, Andree Amelsberg, vice president of US Medical Affairs Oncology and Hematology at Janssen, and Danelle James, Imbruvica clinical science lead at Pharmacyclics LLC, an AbbVie company, discuss the recent expanded approval of...

In this video, David Nash, MD, MBA, Jefferson College of Population Health, explains how COVID-19 has changed the population health landscape, and provides tips for providers who are navigating through this challenging time.

J. Nicholas Dionne-Odom, PhD, APRN, Center for Palliative and Supportive Care, Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, discusses why a telehealth intervention for family caregivers of...

Robert Giugliano, MD, cardiovascular medicine specialist at Brigham and Women's Hospital, discusses the results of the ENGAGE AF-TIMI 48 trial explaining the benefits of treating patients with edoxaban, and why he encourages health care...

Mandeep S Randhawa, MD, division of cardiology, Michigan State University, discusses his recent study and explains why warfarin provides no benefit for ischemic stroke incidence or mortality, as well as increase the risk of hemorrhagic...

Doug Zurawski, PharmD, senior vice president, Clinical Strategy, Kit Check, discusses the results of a recent hospital pharmacy survey and explains the major impact drug shortages have on hospitals, and why hospital pharmacy leaders need to...